Metabolic Bone Disease in Children with Idiopathic Nephrotic Syndrome

被引:0
|
作者
Boraey, Naglaa F. [1 ]
Addosooki, Ahmad [2 ]
Mohammad, Mohammad A. [2 ]
El-Sonbaty, Marwa M. [3 ]
El-Toukhy, Safinaz E. [4 ,5 ]
机构
[1] Sohag Univ, Fac Med, Dept Pediat, Sohag, Egypt
[2] Sohag Univ, Fac Med, Sohag, Egypt
[3] Natl Res Ctr, Dept Child Hlth, Cairo, Egypt
[4] King Abdulaziz Univ, Fac Sci Girls, Jeddah, Saudi Arabia
[5] Natl Res Ctr, Dept Med Biochem, Cairo, Egypt
关键词
Metabolic bone disease; Nephrotic syndrome; Bone mineral density; Osteoporosis; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; MINERAL DENSITY; LONG-TERM;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Children with idiopathic nephrotic syndrome (INS) may be at risk for metabolic bone disease (MBD) because of biochemical derangements caused by the renal disease, as well as the corticosteroid effects on bone. We studied 70 children with INS for clinical, biochemical, and radiological evidence of MBD. These patients were divided into two groups: 55 frequent relapsers (FR; group I), and 15 infrequent relapsers (IFR; group II). Thirty healthy children matched for age and sex constituted the control group. Bone mineral density (BMD) of these children was evaluated by the Achilles Express Quantitative Ultrasound (QUS) device. Univariate and multivariate analyses were performed to analyze factors predictive of low BMD T- score. We observed that nephrotic children had significantly lower mean BMD T- scores compared with controls (-1.99 +/- 0.74 versus -0.39 +/- 0.87; P = <0.0001). Also, children in group I were found to have significantly lower mean BMD T- scores compared with group II (-2.1 +/- 0.67 versus -1.31 +/- 0.64; P = <0.0001). We also observed that 32.7% of group I had osteoporosis compared to none of group II (P= 0.01). Significantly higher doses of steroids over longer duration of therapy were administered to group I compared with group II (P = < 0.0001 and 0.0004 respectively). On multivariate analysis, the only factor found to be predictive of a low BMD T- score was greater cumulative steroid dose (P= 0.02). We concluded that children with INS are at risk for MBD, especially those receiving higher doses of steroids. Regular BMD evaluation and appropriate therapeutic interventions are recommended for these children. The role of prophylactic therapy in such patients needs to be further investigated. [Naglaa F. Boraey, Ahmad Addosooki, Mohammad A. Mohammad; Marwa M. El-Sonbaty, Safinaz E. El-Toukhy. Metabolic Bone Disease in Children with Idiopathic Nephrotic Syndrome. Life Sci J 2012;9(4):275-280]. (ISSN:1097-8135). http://www.lifesciencesite.com. 40
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [21] IMPACT OF TUBERCULOSIS IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME
    KALA, U
    MILNER, LS
    JACOBS, D
    THOMSON, PD
    PEDIATRIC NEPHROLOGY, 1993, 7 (04) : 392 - 395
  • [22] Management of severe idiopathic nephrotic syndrome in children
    Bensman, Albert
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2009, 193 (08): : 1727 - 1734
  • [23] IDIOPATHIC NEPHROTIC SYNDROME - A REVIEW OF 175 CHILDREN
    ESCRIBANO, AF
    LARRAURI, M
    PENA, A
    NAVARRO, M
    NEFROLOGIA, 1989, 9 (04): : 385 - 390
  • [24] Antioxidant status of children with idiopathic nephrotic syndrome
    Om P. Mishra
    Aditya K. Gupta
    Rajniti Prasad
    Ziledar Ali
    Ram S. Upadhyay
    Surendra P. Mishra
    Narendra K. Tiwary
    Franz S. Schaefer
    Pediatric Nephrology, 2011, 26 : 251 - 256
  • [25] SCLEROSTIN LEVELS IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME
    Zampetoglou, Argyroula
    Askiti, Varvara
    Karavanaki, Kyriaki
    Tsentidis, Charalampos
    Stefanidis, Konstantinos
    Mitsioni, Andromachi
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3473 - 3473
  • [26] Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
    Magnasco, Alberto
    Ravani, Pietro
    Edefonti, Alberto
    Murer, Luisa
    Ghio, Luciana
    Belingheri, Mirco
    Benetti, Elisa
    Murtas, Corrado
    Messina, Giovanni
    Massella, Laura
    Porcellini, Maria Gabriella
    Montagna, Michela
    Regazzi, Mario
    Scolari, Francesco
    Ghiggeri, Gian Marco
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (06): : 1117 - 1124
  • [27] CONVENTIONAL THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN
    BRODEHL, J
    CLINICAL NEPHROLOGY, 1991, 35 : S8 - S15
  • [28] Homocysteine Metabolism in Children with Idiopathic Nephrotic Syndrome
    Kundal, Mohan
    Saha, Abhijeet
    Dubey, N. K.
    Kapoor, Kanika
    Basak, Trayambak
    Bhardwaj, Gaurav
    Tanwar, Vinay Singh
    Sengupta, Shantanu
    Batra, Vinita
    Upadhayay, Ashish Dutt
    Bhatt, Ajay
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2014, 7 (02): : 132 - 136
  • [29] Antioxidant status of children with idiopathic nephrotic syndrome
    Mishra, Om P.
    Gupta, Aditya K.
    Prasad, Rajniti
    Ali, Ziledar
    Upadhyay, Ram S.
    Mishra, Surendra P.
    Tiwary, Narendra K.
    Schaefer, Franz S.
    PEDIATRIC NEPHROLOGY, 2011, 26 (02) : 251 - 256
  • [30] The role of probiotics in children with Idiopathic Nephrotic Syndrome
    Farella, I.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53